HEAT BIOLOGICS, INC. Sales Agreements
7 Contracts & Agreements
- Sales Agreement, dated December 8, 2023, by and between NightHawk Biosciences, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on December 8, 2023)
- Ordering Agreement between Lonza Sales AG and Elusys Therapeutcs, Inc (Filed With SEC on March 31, 2023)
- Ordering Agreement between Lonza Sales AG and Elusys Therapeutcs, Inc (Filed With SEC on March 31, 2023)
- Amended and Restated Sales Agreement, dated August 24, 2020, among Heat Biologics, Inc., B. Riley Securities, Inc. and Cantor Fitzgerald & Co (Filed With SEC on August 24, 2020)
- Amendment No. 1, dated April 23, 2020, to the At Market Issuance Sales Agreement, by and between Heat Biologics, Inc. and B. Riley FBR, Inc. dated April 3, 2019 (Filed With SEC on April 23, 2020)
- At Market Issuance Sales Agreement, dated April 3, 2019, by and between Heat Biologics, Inc. and B. Riley FBR, Inc (Filed With SEC on April 4, 2019)
- At Market Issuance Sales Agreement, dated August 15, 2016, by and between Heat Biologics, Inc. and FBR Capital Markets & Co (Filed With SEC on August 15, 2016)
